# Cardiovascular Effects of Apelin In Healthy Volunteers

> **NCT02259686** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Edinburgh** · enrollment: 14 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Apelin 1mg subcutaneous
- **DRUG:** Apelin 1mg intravenous
- **DRUG:** Apelin 5mg subcutaneous
- **DRUG:** Apelin 5mg intravenous
- **DRUG:** Apelin 10 mg subcutaneous

## Key facts

- **NCT ID:** NCT02259686
- **Lead sponsor:** University of Edinburgh
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2015-06-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02259686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02259686, "Cardiovascular Effects of Apelin In Healthy Volunteers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02259686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*